Tag | Content |
---|
EnhancerAtlas ID | HS109-22100 |
Organism | Homo sapiens |
Tissue/cell | Kasumi-1 |
Coordinate | chr8:56831900-56832580 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
BHLHE41 | MA0636.1 | chr8:56832491-56832501 | GTCACGTGAC | + | 6.02 | BHLHE41 | MA0636.1 | chr8:56832491-56832501 | GTCACGTGAC | - | 6.02 | MITF | MA0620.2 | chr8:56832487-56832505 | CTTTGTCACGTGACCCCA | + | 6.47 | MITF | MA0620.2 | chr8:56832487-56832505 | CTTTGTCACGTGACCCCA | - | 6.47 | USF1 | MA0093.2 | chr8:56832491-56832502 | GTCACGTGACC | + | 6.14 | USF2 | MA0526.2 | chr8:56832489-56832505 | TTGTCACGTGACCCCA | - | 6.36 |
|
| Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
SE_09229 | chr8:56829792-56833477 | CD14 | SE_10228 | chr8:56829813-56833110 | CD19_Primary | SE_10861 | chr8:56823723-56864289 | CD20 | SE_53331 | chr8:56831844-56832761 | Spleen | SE_58404 | chr8:56735034-56858189 | Ly1 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH08I055917 | chr8 | 56829967 | 56833211 |
|
Enhancer Sequence | TAAGTTAGTG TAGAGTTTGA GTGAGAAGAA TGAGGAACAT AAATATGAAT GCTCTGTTAA 60 TATAGTGCTT TTCATAGAAA TAATGGAATA GAATACGCTT CACTGCCGGG TCTGGAAACC 120 CTCCCTCTGT CAGGGTGATT TAGAAATTGA CTGATTTTAC CATGGAGGGA TGGGATGGGC 180 CACAGGCTGG GGTTTGAAGA AAGAATCTAT AATCCTTTTG GTCTTAACTA TTAGGCAAAT 240 TTAGCTTCCT GGTCTCAGAA AGAAAAAACA CACCCACAAA AAGAAAAACC CATGCCCGTG 300 GGAACAAGTA ACTTCCTCCT CCTGGGGCTG CTTGAAAACC CTAATCTTCC TCTCACCAGG 360 CCAAGTCCCT TCCCTTCTCA GCGGGAGGCC AGCTGGGGCA TCCAAAAAGC CACAACGGGC 420 CCTGGGGAGG GAGAATGCAC CCGTCTGGGT GAGCAGTTGA ACGTGCATTG GCTGAGGTGT 480 GAGGCTCGGG AAATGGCTCT CCAGGCAAAG ACGCTGCTTG GAGGCAACTT TATAATTCTT 540 TGTACCTGGG AAAGTGAAGG GTTGGGCGGG GGGAGTGGGG GTGGGAGCTT TGTCACGTGA 600 CCCCACTCTT TGCTTCTTTG TCTGTCCTCC AACTTAACAT GGCTTGAGGC TGAAAAACAG 660 AATTCCTCAT TTTTTACTCA 680
|